Has anyone even tried calling the company to ask about pbt2? I called months ago and the company rep reiterated that pbt2 was well and truly on the back burner. The main objective is to get 434 trials ready. Until then I expect crickets from pbt2, which could be well into next year before any news arrives.
That said, I don’t know how prudent it would be to have a deal with pbt2 at the forefront of anyone’s mind. Could lead to continuous disappointment.
gltah and dyor
Pfizer / Antimicrobial-resistance fund, page-17
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $4.497K | 1.410M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 16550495 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130888260 | 30 |
View Market Depth
| Last trade - 10.28am 07/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |